Effects of subthalamic nucleus deep brain stimulation on the speech of Spanish-speaking Parkinson’s disease patients during the first year of treatment
Efeitos da estimulação cerebral profunda do núcleo subtalâmico na fala de pacientes com doença de Parkinson de língua espanhola durante o primeiro ano de tratamento
Nicolás Castillo-Triana; Maryluz Camargo-Mendoza; Óscar Bernal-Pacheco
Abstract
Keywords
Resumo
RESUMO:
Palavras-chave
Referências
1 Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review. JAMA. 2020;323(6):548-60.
2 Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson’s disease. Subcell Biochem. 2012;65:389-455.
3 Reich SG, Savitt JM. Parkinson’s disease. Med Clin North Am. 2019;103(2):337-50.
4 Bailey M, Goldman JG. Characterizing cognitive impairment in Parkinson’s disease. Semin Neurol. 2017;37(2):167-75.
5 Bocanegra García Y, Trujillo-Orrego N, Pineda Salazar D. Demencia y deterioro cognitivo leve en la enfermedad de Parkinson: una revisión [Dementia and mild cognitive impairment in Parkinson's Disease: a review]. Rev Neurol. 2014;59(12):555-69.
6 Getz SJ, Levin B. Cognitive and neuropsychiatric features of early Parkinson’s disease. Arch Clin Neuropsychol. 2017;32(7):769-85.
7 Dumican M, Watts C. Self-perceptions of speech, voice, and swallowing in motor phenotypes of Parkinson’s disease. Clin Park Relat Disord. 2020;3:100074.
8 Suttrup I, Warnecke T. Dysphagia in Parkinson’s Disease. Dysphagia. 2016;31(1):24-32.
9 Hartelius L, Svensson P. Speech and swallowing symptoms associated with Parkinson’s disease and multiple sclerosis: a survey. Folia Phoniatr Logop. 1994;46(1):9-17.
10 Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson’s disease: pathophysiology, medical management, and surgical approaches. Neurodegener Dis Manag. 2018;8(5):337-48.
11 Hammer MJ, Barlow SM. Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control. Exp Brain Res. 2010;201(3):401-9.
12 Hegland KW, Troche M, Brandimore A. Relationship between respiratory sensory perception, speech, and swallow in Parkinson’s disease. Mov Disord Clin Pract. 2019;6(3):243-9.
13 Theodoros D. Speech Disorders in Parkinson’s Disease. In: Theodoros D, Ramig L, editors. Communication and swallowing in Parkinson’s disease. San Diego: Plural Publishing; 2011. p. 51-88.
14 Thijs Z, Watts CR. Perceptual characterization of voice quality in nonadvanced stages of Parkinson’s disease. J Voice. 2022;36(2):293.e11-8.
15 Skodda S. Speech and voice disorders in Parkinson’s disease. In: Harrison AE, editor. Speech disorders: causes, treatment and social effects. London: Nova Science Publishers; 2010. p. 1-41.
16 Caekebeke JF, Jennekens-Schinkel A, Van der Linden ME, Buruma OJ, Roos RA. The interpretation of dysprosody in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1991;54(2):145-8.
17 Ma JK-Y, Schneider CB, Hoffmann R, Storch A. Speech prosody across stimulus types for individuals with Parkinson’s disease. J Parkinsons Dis. 2015;5(2):291-9.
18 Fox SH, Katzenschlager R, Lim S-Y, Barton B, De Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord. 2018;33(8):1248-66.
19 Kogan M, McGuire M, Riley J. Deep brain stimulation for Parkinson disease. Neurosurg Clin N Am. 2019;30(2):137-46.
20 Malek N. Deep brain stimulation in Parkinson’s disease. Neurol India. 2019;67(4):968-78.
21 Miocinovic S, Somayajula S, Chitnis S, Vitek JL. History, applications, and mechanisms of deep brain stimulation. JAMA Neurol. 2013;70(2):163-71.
22 Okun MS. Deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2012;367(16):1529-38.
23 Xu H, Zheng F, Krischek B, Ding W, Xiong C, Wang X, et al. Subthalamic nucleus and globus pallidus internus stimulation for the treatment of Parkinson’s disease: a systematic review. J Int Med Res. 2017;45(5):1602-12.
24 Ossowska K. Zona incerta as a therapeutic target in Parkinson’s disease. J Neurol. 2020;267(3):591-606.
25 Dayal V, Limousin P, Foltynie T. Subthalamic nucleus deep brain stimulation in Parkinson’s disease: the effect of varying stimulation parameters. J Parkinsons Dis. 2017;7(2):235-45.
26 Aldridge D, Theodoros D, Angwin A, Vogel AP. Speech outcomes in Parkinson’s disease after subthalamic nucleus deep brain stimulation: a systematic review. Parkinsonism Relat Disord. 2016;33:3-11.
27 Murdoch BE. Surgical approaches to treatment of Parkinson’s disease: implications for speech function. Int J Speech Lang Pathol. 2010;12(5):375-84.
28 Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Yoneyama N, Hara K, et al. Characteristic laryngoscopic findings in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder. J Neural Transm. 2015;122(12):1663-72.
29 Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Yoneyama N, Hara K, et al. Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry. 2015;86(8):856-64.
30 Tanaka Y, Tsuboi T, Watanabe H, Kajita Y, Fujimoto Y, Ohdake R, et al. Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Neurol. 2015;262(5):1173-81.
31 Lee VS, Zhou XP, Rahn DA 3rd, Wang E, Jiang JJ. Perturbation and nonlinear dynamic analysis of acoustic phonatory signal in Parkinsonian patients receiving deep brain stimulation. J Commun Disord. 2008;41(6):485-500.
32 Zhou XP, Lee VS, Wang EQ, Jiang JJ. Evaluation of the effects of deep brain stimulation of the subthalamic nucleus and levodopa treatment on Parkinsonian voice using perturbation, nonlinear dynamic, and perceptual analysis. Folia Phoniatr Logop. 2009;61(4):189-99.
33 Tanaka Y, Tsuboi T, Watanabe H, Kajita Y, Nakatsubo D, Fujimoto Y, et al. Articulation features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Parkinsons Dis. 2016;6(4):811-9.
34 Tripoliti E, Zrinzo L, Martínez-Torres I, Frost E, Pinto S, Foltynie T, et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology. 2011;76(1):80-6.
35 Dromey C, Kumar R, Lang A, Lozano A. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord. 2000;15(6):1132-8.
36 Karlsson F, Olofsson K, Blomstedt P, Linder J, van Doorn J. Pitch variability in patients with parkinson’s disease: effects of deep brain stimulation of caudal zona incerta and subthalamic nucleus. J Speech Lang Hear Res. 2013;56(1):150-8.
37 Karlsson F, Unger E, Wahlgren S, Blomstedt P, Linder J, Nordh E, et al. Deep Brain stimulation of caudal zona incerta and subthalamic nucleus in patients with parkinson’s disease: effects on diadochokinetic rate. Parkinsons Dis. 2011;2011:605607.
38 Hustad KC. The relationship between listener comprehension and intelligibility scores for speakers with dysarthria. J Speech Lang Hear Res. 2008;51(3):562-73.
39 Eklund E, Qvist J, Sandström L, Viklund F, Van Doorn J, Karlsson F. Perceived articulatory precision in patients with Parkinson’s disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta. Clin Linguist Phon. 2015;29(2):150-66.
40 Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Hattori M, Kawabata K, et al. Early detection of speech and voice disorders in Parkinson’s disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study. J Neural Transm. 2017;124(12):1547-56.
41 Tanaka Y, Tsuboi T, Watanabe H, Nakatsubo D, Maesawa S, Kato S, et al. Longitudinal speech change after subthalamic nucleus deep brain stimulation in Parkinson’s disease patients: a 2-year prospective study. J Parkinsons Dis. 2020;10(1):131-40.
42 Lundgren S, Saeys T, Karlsson F, Olofsson K, Blomstedt P, Linder J, et al. Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson’s disease: effects on voice intensity. Parkinsons Dis. 2011;2011:658956.
43 D’Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR. Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment. J Voice. 2008;22(3):365-72.
44 Hoffman-Ruddy B, Schulz G, Vitek J, Evatt M. A preliminary study of the effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on voice and speech characteristics in Parkinson’s disease (PD). Clin Linguist Phon. 2001;15(1-2):97-101.
45 Gentil M, Pinto S, Pollack P, Benabid AL. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain Lang. 2003;85(2):190-6.
46 Klostermann F, Ehlen F, Vesper J, Nubel K, Gross M, Marzinzik F, et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2008;79(5):522-9.
47 Martel-Sauvageau V, Macoir J, Langlois M, Prud’Homme M, Cantin L, Roy JP. Changes in vowel articulation with subthalamic nucleus deep brain stimulation in dysarthric speakers with Parkinson’s disease. Parkinsons Dis. 2014;2014:487035.
48 Sarac ET, Yilmaz A, Aydinli FE, Yildizgoren MT, Okuyucu EE, Okuyucu S, et al. Investigating the effects of subthalamic nucleus-deep brain stimulation on the voice quality. Somatosens Mot Res. 2020;37(3):157-64.
49 Romann AJ, Beber BC, Cielo CA, Rieder CRM. Acoustic voice modifications in individuals with Parkinson disease submitted to deep brain stimulation. Int Arch Otorhinolaryngol. 2019;23(2):203-8.
50 Valálik I, Smehák G, Bognár L, Csókay A. Voice acoustic changes during bilateral subthalamic stimulation in patients with Parkinson’s disease. Clin Neurol Neurosurg. 2011;113(3):188-95.
51 Xie Y, Zhang Y, Zheng Z, Liu A, Wang X, Zhuang P, et al. Changes in speech characters of patients with Parkinson’s disease after bilateral subthalamic nucleus stimulation. J Voice. 2011;25(6):751-8.
52 Ahlberg E, Laakso K, Hartelius L. Perceived changes in communication as an effect of STN surgery in parkinson’s disease: a qualitative interview study. Parkinsons Dis. 2011;2011:540158.
53 Frost E, Tripoliti E, Hariz MI, Pring T, Limousin P. Self-perception of speech changes in patients with Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. Int J Speech Lang Pathol. 2010;12(5):399-404.
54 Wertheimer J, Gottuso AY, Nuno M, Walton C, Duboille A, Tuchman M, et al. The impact of STN deep brain stimulation on speech in individuals with Parkinson’s disease: the patient’s perspective. Parkinsonism Relat Disord. 2014;20(10):1065-70.
55 Cruz AN, Beber BC, Olchik MR, Chaves ML, Rieder CR, Dornelles S. Aspects of oral communication in patients with Parkinson’s disease submitted to deep brain stimulation. CoDAS. 2016;28(4):480-5.
56 Hartinger M, Tripoliti E, Hardcastle WJ, Limousin P. Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson’s disease using electropalatography: a pilot study. Clin Linguist Phon. 2011;25(3):210-30.
57 Hammer MJ, Barlow SM, Lyons KE, Pahwa R. Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson’s disease. J Neurol. 2010;257(10):1692-702.
58 Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson’s disease. J Neurol. 2003;250(2):179-87.
59 Moreau C, Pennel-Ployart O, Pinto S, Plachez A, Annic A, Viallet F, et al. Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson’s disease. Mov Disord. 2011;26(4):659-63.
60 Rousseaux M, Krystkowiak P, Kozlowski O, Ozsancak C, Blond S, Destée A, et al. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. J Neurol. 2004;251(3):327-34.
61 Skodda S. Effect of deep brain stimulation on speech performance in Parkinson’s disease. Parkinsons Dis. 2012;2012:850596.
62 Aviles-Olmos I, Kefalopoulou Z, Tripoliti E, Candelario J, Akram H, Martínez-Torres I, et al. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry. 2014;85(12):1419-25.
63 Tripoliti E, Limousin P, Foltynie T, Candelario J, Aviles-Olmos I, Hariz MI, et al. Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson’s disease. Mov Disord. 2014;29(4):532-8.
64 Tripoliti E, Limousin P, Tisch S, Borrell E, Hariz M. Speech in Parkinson’s disease following subthalamic nucleus deep brain stimulation: preliminary results. J Med Speech-Lang Pathol [Internet]. 2006 [cited 2023 Feb 13];14(1):309-15. Available from:
65 Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649-53.
66 Hariz MI, Krack P, Melvill R, Jorgensen JV, Hamel W, Hirabayashi H, et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg. 2003;80(1-4):96-101.
67 Tanei T, Kajita Y, Kaneoke Y, Takebayashi S, Nakatsubo D, Wakabayashi T. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Acta Neurochir. 2009;151(6):589-94.
68 Kojovic M, Mir P, Trender-Gerhard I, Schneider SA, Pareés I, Edwards MJ, et al. Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication. J Neurol. 2014;261(6):1080-9.
69 Li K, Haase R, Rüdiger H, Reimann M, Reichmann H, Wolz M, et al. Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease. Sci Rep. 2017;7(1):7012.
70 Ortega-Garcia J, Gonzalez-Rodriguez J, Marrero-Aguiar V. AHUMADA: a large corpus in Spanish for speaker characterization and identification. Speech Commun. 2000;31(2):255-64.
71 Boersma P. Praat, a system for doing phonetics by computer. Glot Int [Internet]. 2001 [cited 2023 Feb 13];5(9-10):341-5. Available from:
72 Delgado J, León NM, Jiménez A, Izquierdo LM. Análisis acústico de la voz: medidas temporales, espectrales y cepstrales en la voz normal con el Praat en una muestra de hablantes de español [Acoustic analysis of voice: calculation of temporal, spectral and cepstral measures with Praat in normal voice in a sample of Spanish-speaking speakers]. Rev Investig Logop [Internet]. 2017 [cited 2023 Feb 13];7(2):108-27. Available from:
73 Moya-Galé G, Goudarzi A, Bayés Á, McAuliffe M, Bulté B, Levy ES. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers with Parkinson’s Disease. Am J Speech Lang Pathol. 2018;27(1):154-65.
74 Chiu YF, Neel A. Predicting Intelligibility deficits in Parkinson’s disease with perceptual speech ratings. J Speech Lang Hear Res. 2020;63(2):433-43.
75 Neel AT. Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease. J Speech Lang Hear Res. 2009;52(4):1021-33.
76 Masalski M, Krecicki T. Self-test web-based pure-tone audiometry: validity evaluation and measurement error Analysis. J Med Internet Res. 2013;15(4):e71.
77 Separar en Sílabas [Internet]. [cited 2023 Feb 13]. Available from:
78 Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. Philadelphia: Elsevier Health Sciences; 2005.
79 R Core Team. R: a language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing; 2023 [cited 2023 Feb 13]. Available from:
80 Gorris C, Ricci A, Vanoni F, Poggioli M, Vaschetto R, Garzaro M, et al. Acoustic analysis of normal voice patterns in italian adults by using praat. J Voice. 2020;34(6):961.e9-18.
81 Roth F, Worthington C. Treatment resource manual for speech-language pathology. Albany: Singular Publishing; 2001.
82 Abeyesekera A, Adams S, Mancinelli C, Knowles T, Gilmore G, Delrobaei M, et al. Effects of deep brain stimulation of the subthalamic nucleus settings on voice quality, intensity, and prosody in parkinson’s disease: preliminary evidence for speech optimization. Can J Neurol Sci. 2019;46(3):287-94.
83 Grover T, Georgiev D, Kalliola R, Mahlknecht P, Zacharia A, Candelario J, et al. Effect of low versus high frequency subthalamic deep brain stimulation on speech intelligibility and verbal fluency in Parkinson’s disease: a double-blind study. J Parkinsons Dis. 2019;9(1):141-51.
84 Dias AE, Barbosa MT, Limongi JC, Barbosa ER. Speech disorders did not correlate with age at onset of Parkinson’s disease. Arq Neuropsiquiatr. 2016;74(2):117-21.
85 Brown KA, Spencer KA. The relationship between speech characteristics and motor subtypes of Parkinson’s disease. Am J Speech Lang Pathol. 2020;29(4):2145-54.
86 Majdinasab F, Karkheiran S, Soltani M, Moradi N, Shahidi G. Relationship between voice and motor disabilities of Parkinson’s disease. J Voice. 2016;30(6):768.e17-22.
Submetido em:
07/08/2023
Aceito em:
01/02/2024
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email